Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06635863
PHASE4

Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat

Sponsor: Roderick Tung

View on ClinicalTrials.gov

Summary

Ventricular tachycardia (VT, a potentially fatal condition where the ventricle of the heart beats rapidly) superimposed on non-ischemic cardiomyopathy (NICM, a disease of heart with broad etiologies except coronary artery disease). This disease has been associated with inflammation in the heart. The purpose of this study is to assess the benefit of immunosuppressive therapy to suppress the VT, improve heart function, avoid invasive intervention and hospitalization. Positron Emission Tomography (PET) imaging shows inflammation in the heart. After enrollment, baseline tests (including physical exams, blood tests, genetic test, electrocardiography, echocardiography) will be done. Next, will be an 8-week medication regimen which contains either immunosuppressive drugs or standard GDMT without immunosuppressant medication. Some of the examinations will be repeated during the study to evaluate the treatment response and monitor any adverse events.

Official title: Immunosuppression Versus Medical Therapy for UN-explained Low Ejection Fraction and VT

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2024-11-01

Completion Date

2027-10

Last Updated

2024-12-05

Healthy Volunteers

No

Interventions

DRUG

Prednisone 40mg

Prednisone 40mg x 8weeks

Locations (1)

Banner - University Medical Center, Phoenix campus

Phoenix, Arizona, United States